416 related articles for article (PubMed ID: 17379467)
1. UV-vis and FTIR-ATR spectroscopic techniques to study the inclusion complexes of genistein with beta-cyclodextrins.
Crupi V; Ficarra R; Guardo M; Majolino D; Stancanelli R; Venuti V
J Pharm Biomed Anal; 2007 May; 44(1):110-7. PubMed ID: 17379467
[TBL] [Abstract][Full Text] [Related]
2. UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complex.
Stancanelli R; Ficarra R; Cannavà C; Guardo M; Calabrò ML; Ficarra P; Ottanà R; Maccari R; Crupi V; Majolino D; Venuti V
J Pharm Biomed Anal; 2008 Aug; 47(4-5):704-9. PubMed ID: 18400444
[TBL] [Abstract][Full Text] [Related]
3. Improvement of water solubility of non-competitive AMPA receptor antagonists by complexation with beta-cyclodextrin.
Stancanelli R; Crupi V; De Luca L; Ficarra P; Ficarra R; Gitto R; Guardo M; Iraci N; Majolino D; Tommasini S; Venuti V
Bioorg Med Chem; 2008 Sep; 16(18):8706-12. PubMed ID: 18762428
[TBL] [Abstract][Full Text] [Related]
4. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
5. Physico-chemical characterization of an amphiphilic cyclodextrin/genistein complex.
Cannavà C; Crupi V; Ficarra P; Guardo M; Majolino D; Mazzaglia A; Stancanelli R; Venuti V
J Pharm Biomed Anal; 2010 Apr; 51(5):1064-8. PubMed ID: 20036091
[TBL] [Abstract][Full Text] [Related]
6. Influence of the "host-guest" interactions on the mobility of genistein/beta-cyclodextrin inclusion complex.
Crupi V; Majolino D; Paciaroni A; Stancanelli R; Venuti V
J Phys Chem B; 2009 Aug; 113(31):11032-8. PubMed ID: 19603804
[TBL] [Abstract][Full Text] [Related]
7. Curve-fitting FTIR studies of loratadine/hydroxypropyl-beta-cyclodextrin inclusion complex induced by co-grinding process.
Lin SY; Hsu CH; Sheu MT
J Pharm Biomed Anal; 2010 Nov; 53(3):799-803. PubMed ID: 20619996
[TBL] [Abstract][Full Text] [Related]
8. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.
Aleem O; Kuchekar B; Pore Y; Late S
J Pharm Biomed Anal; 2008 Jul; 47(3):535-40. PubMed ID: 18367363
[TBL] [Abstract][Full Text] [Related]
9. The enhancement of isoflavones water solubility by complexation with modified cyclodextrins: a spectroscopic investigation with implications in the pharmaceutical analysis.
Stancanelli R; Mazzaglia A; Tommasini S; Calabrò ML; Villari V; Guardo M; Ficarra P; Ficarra R
J Pharm Biomed Anal; 2007 Aug; 44(4):980-4. PubMed ID: 17482414
[TBL] [Abstract][Full Text] [Related]
10. Molecular simulation of hydroxypropyl-beta-cyclodextrin with hydrophobic selective Cox-II chemopreventive agent using host-guest phenomena.
Sinha VR; Nanda A; Chadha R; Goel H
Acta Pol Pharm; 2011; 68(4):585-92. PubMed ID: 21796941
[TBL] [Abstract][Full Text] [Related]
11. Study of solubility of isoproturon by its complexation with beta-cyclodextrin.
Manolikar MK; Sawant MR
Chemosphere; 2003 Jun; 51(8):811-6. PubMed ID: 12668040
[TBL] [Abstract][Full Text] [Related]
12. Fosinopril-cyclodextrin inclusion complexes: phase solubility and physicochemical analysis.
Sbârcea L; Udrescu L; Drăgan L; Trandafirescu C; Szabadai Z; Bojiţă M
Pharmazie; 2011 Aug; 66(8):584-9. PubMed ID: 21901980
[TBL] [Abstract][Full Text] [Related]
13. Interaction between nitroheterocyclic compounds with beta-cyclodextrins: phase solubility and HPLC studies.
de Melo NF; Grillo R; Rosa AH; Fraceto LF
J Pharm Biomed Anal; 2008 Aug; 47(4-5):865-9. PubMed ID: 18534804
[TBL] [Abstract][Full Text] [Related]
14. Preparation and study on the inclusion complexes of two tanshinone compounds with beta-cyclodextrin.
Yuexian F; Junfen L; Chuan D
Spectrochim Acta A Mol Biomol Spectrosc; 2005 Jan; 61(1-2):135-40. PubMed ID: 15556431
[TBL] [Abstract][Full Text] [Related]
15. [Study on the inclusion complexation interaction of beta-cyclodextrin and beta-carotene by UV-Vis spectra].
Feng GZ; Lu K; Li HP
Guang Pu Xue Yu Guang Pu Fen Xi; 2004 Sep; 24(9):1099-102. PubMed ID: 15762533
[TBL] [Abstract][Full Text] [Related]
16. Inclusion complexes of pyrimethamine in 2-hydroxypropyl-beta-cyclodextrin: characterization, phase solubility and molecular modelling.
de Araújo MV; Vieira EK; Lázaro GS; de Souza Conegero L; Ferreira OP; Almeida LS; Barreto LS; da Costa NB; Gimenez IF
Bioorg Med Chem; 2007 Sep; 15(17):5752-9. PubMed ID: 17583516
[TBL] [Abstract][Full Text] [Related]
17. A characterization study of resveratrol/sulfobutyl ether-β-cyclodextrin inclusion complex and in vitro anticancer activity.
Venuti V; Cannavà C; Cristiano MC; Fresta M; Majolino D; Paolino D; Stancanelli R; Tommasini S; Ventura CA
Colloids Surf B Biointerfaces; 2014 Mar; 115():22-8. PubMed ID: 24321846
[TBL] [Abstract][Full Text] [Related]
18. The inclusion complexes of hesperetin and its 7-rhamnoglucoside with (2-hydroxypropyl)-beta-cyclodextrin.
Tommasini S; Calabrò ML; Stancanelli R; Donato P; Costa C; Catania S; Villari V; Ficarra P; Ficarra R
J Pharm Biomed Anal; 2005 Sep; 39(3-4):572-80. PubMed ID: 15985355
[TBL] [Abstract][Full Text] [Related]
19. Complexation of morin with three kinds of cyclodextrin. A thermodynamic and reactivity study.
Jullian C; Orosteguis T; Pérez-Cruz F; Sánchez P; Mendizabal F; Olea-Azar C
Spectrochim Acta A Mol Biomol Spectrosc; 2008 Nov; 71(1):269-75. PubMed ID: 18262835
[TBL] [Abstract][Full Text] [Related]
20. Investigation of curcumin-cyclodextrin inclusion complexation in aqueous solutions containing various alcoholic co-solvents and alginates using an UV-VIS titration method. Studies of curcumin and curcuminoides, XXXV.
Hegge AB; Másson M; Kristensen S; Tønnesen HH
Pharmazie; 2009 Jun; 64(6):382-9. PubMed ID: 19618675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]